Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Ligand. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115490730B reveals a high-yield method for chiral BIDIME selenium/sulfur ligands, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN109928995A introduces high-efficiency chiral ligands for carbonyl hydrogenation. Achieve superior enantioselectivity and scalable catalyst production for pharmaceutical manufacturing.
Patent CN121517463A introduces a novel N-N axial chiral ligand synthesis. Achieve cost reduction in ligand manufacturing with scalable, high-purity solutions for pharma.
Efficient synthesis of planar chiral ferrocenes using chiral amino acids. Reliable supplier for high-purity pharmaceutical intermediates with reduced manufacturing costs.
Patent CN110283036B details a novel column chromatography method for separating chiral diene ligands with 100% ee, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN109970713B details novel amino acid-based Ir(III) catalysts enabling high-efficiency asymmetric C-H activation for cost-effective API manufacturing.
Patent CN103087105A discloses novel chiral phosphine ligands enabling high-efficiency asymmetric hydrogenation of beta-aryl enamides with exceptional enantioselectivity.
Patent CN111018923B details novel chiral ligands enhancing catalytic efficiency. Offers supply chain stability and cost reduction in fine chemical manufacturing for global partners.
Patent CN107445999A enables high-purity chiral cyclic amines via Rhodium catalysis. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable technology.
Novel axially chiral ligand enables high-yield asymmetric synthesis. Reduces costs and improves supply chain reliability for chiral aminoamide manufacturing.
Novel cobalt-catalyzed asymmetric hydrosilylation patent CN116554223A offers high enantioselectivity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN113087640B reveals a cost-effective chiral ONO tridentate ligand and cobalt complex, offering scalable solutions for asymmetric synthesis and supply chain optimization.
Patent CN112209967B reveals high-yield ligand synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN114539327B reveals stable P,N,N-ligand for propargyl conversion. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN121378129A reveals novel binaphthyl ligands for asymmetric catalysis. Enhance enantioselectivity and streamline pharmaceutical intermediate manufacturing supply chains.
Novel synthesis of binaphthyl NN-dioxide ligands via Pd-catalyzed carbonylation. High yield over 75 percent and purity exceeding 95 percent. Reliable supplier for asymmetric catalysis.
Patent CN120554424A reveals a novel ferrocene-based P,N,N-ligand offering superior stability and stereoselectivity for cost-effective pharmaceutical intermediate manufacturing.
Patent CN121085785A reveals ferrocene-based ligands for asymmetric allylic substitution, offering high enantioselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN109851634B discloses Yu-Phos ligands for asymmetric catalysis. Enables cost reduction in pharmaceutical intermediate manufacturing with high stereoselectivity.
Patent CN114478632B reveals high-ee chiral ligands for hydroformylation. Enhance supply chain reliability and reduce manufacturing costs with scalable synthesis.